Biomarkers – News and Features

Experts discuss how academic publishing must change to support open science, transparency and global accessibility in a digital-first research world.

A combination of routine eye scans and AI has created a powerful new way for measuring short-sightedness to better predict people’s long-term risk of serious retinal damage, a new study suggests.

Researchers in Finland found Alzheimer’s-related blood biomarkers in adults as young as 41, decades before symptoms appear. The study linked these markers to kidney function, maternal influence and genetic risk factors.

Discover what glycan analysis can reveal about protein behavior and how it can be used to boost biologic performance and ensure therapeutic quality in biopharmaceutical drug development.

Researchers at Mount Sinai discovered that a long non-coding RNA, LINC00473, promotes resilience to depression in females by influencing decision-making in the brain’s prefrontal cortex. The molecule enhances sensitivity to regret and sunk costs.

Discover how Agilent's AssayMAP Bravo and RapidFire systems accelerate drug discovery with automation and rapid, reliable mass spectrometry.

The findings have sparked concern among the fishery’s many stakeholders and highlight a need for new tools that can help balance economic and ecological priorities—this study may help with that.

Four years after pre-surgery treatment with a novel combination of immune checkpoint inhibitors, nivolumab and relatlimab, 87% of patients with stage III melanoma remained alive.

By improving sensitivity and boosting signal amplification, nanomaterials are heralding a new era for biomarker detection.

A flexible wristband developed by researchers at UC San Diego monitors glucose, lactate, alcohol and cardiovascular indicators, enabling real-time health tracking.